openPR Logo
Press release

C-reactive Protein Testing Market Expected to Reach $4.0 Billion by 2031

02-16-2024 09:59 PM CET | Health & Medicine

Press release from: Transparency Market Research

C-reactive Protein Testing

C-reactive Protein Testing

The latest report on the global C-reactive protein (CRP) testing market forecasts significant growth, with the market projected to exceed $4.0 billion by the end of 2031. The market, which was valued at $3.1 billion in 2022, is anticipated to grow at a steady CAGR of 2.9% from 2023 to 2031.

Get Sample PDF Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1899

Key Factors Driving Market Growth

The global CRP testing market is expected to experience substantial growth due to several key factors:

Rise in Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, and autoimmune diseases is driving the demand for CRP testing for diagnosis and management. Elevated CRP levels are associated with inflammation, making CRP testing a valuable tool in assessing disease severity and monitoring treatment effectiveness.

Advances in Technology: Technological advancements, including the development of high-sensitivity CRP assays and point-of-care CRP testing devices, are providing lucrative opportunities for market players. These advancements improve the accuracy, efficiency, and accessibility of CRP testing, contributing to market growth.

Demand for Point-of-Care Testing (POCT): The surge in demand for POCT for CRP testing is driving market expansion. POCT enables rapid testing in primary care settings, emergency departments, and other point-of-care locations, facilitating quicker diagnosis and treatment. The convenience and cost-effectiveness of POCT are driving its adoption, especially in the wake of the COVID-19 pandemic.

Market Segmentation and Regional Analysis

Test Type: The market is segmented into standard CRP tests and high-sensitivity CRP tests. The standard CRP test segment held the largest market share in 2022, reflecting its widespread use in clinical practice.

Type of Assay: Immunoturbidimetry emerged as the dominant assay type in 2022, offering high sensitivity and specificity in measuring CRP levels. It is widely used in clinical laboratories worldwide.

Indication: Inflammatory diseases accounted for a significant market share in 2022, driven by the increasing prevalence of conditions such as rheumatoid arthritis, lupus, and inflammatory bowel disease. CRP testing plays a crucial role in the diagnosis and management of these diseases.

End-user: Independent diagnostic laboratories led the market in 2022, fueled by the growing trend of home care diagnostics and testing. These laboratories offer convenient testing services, including direct-to-home testing, catering to patient preferences.

Regional Analysis: North America dominated the market in 2022, driven by the adoption of POCT, technological advancements, and the prevalence of inflammatory diseases. Asia Pacific is expected to witness significant growth, fueled by the rise in chronic diseases and demand for early diagnosis and treatment.

Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1899

Key Players and Recent Developments

Prominent players in the global CRP testing market include Agilent Technologies, Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Creative Diagnostics, DxGen Corp., CTK Biotech, Inc., Getein Biotech, Inc., Goldsite Diagnostics, Inc., OptiBio Co., Ltd., and Nanjing Vazyme Biotech Co., Ltd.

Recent developments include partnerships for quality control material development, collaborations for new assay development, and product launches aimed at enhancing testing capabilities.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release C-reactive Protein Testing Market Expected to Reach $4.0 Billion by 2031 here

News-ID: 3388367 • Views:

More Releases from Transparency Market Research

Wireless Sensors Market to be Worth USD 80.6 Bn by 2036 - By Sensor Type / By Connectivity / By Application | U.S. • Japan • U.K. • Brazil
Wireless Sensors Market to be Worth USD 80.6 Bn by 2036 - By Sensor Type / By Co …
The global wireless sensors market is witnessing strong growth momentum, driven by rising digital transformation across industrial, infrastructure, healthcare, and smart city ecosystems. According to industry analysis, the wireless sensors market was valued at US$ 17.4 billion in 2025 and is projected to reach US$ 80.6 billion by 2036, expanding at a robust CAGR of 14.7% during the forecast period from 2026 to 2036. Access an overview of significant conclusions from
Skin Care Market to be Worth USD 318.1 Bn by 2036 - By Type / By Skin Type / By Distribution Channel | U.S. • Japan • Brazil • U.K.
Skin Care Market to be Worth USD 318.1 Bn by 2036 - By Type / By Skin Type / By …
The global skin care market continues to demonstrate steady growth, reflecting the increasing integration of skincare into daily health and wellness routines. The market was valued at US$ 195.8 billion in 2025 and is projected to reach US$ 318.1 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.5% from 2026 to 2036. Review critical insights and findings from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=340 The industry growth is
Healthcare Contract Research Outsourcing Market Outlook 2036: Market to Reach US$ 132.7 Billion at 7.2% CAGR Driven by Clinical Trial Complexity and Rising R&D Investments
Healthcare Contract Research Outsourcing Market Outlook 2036: Market to Reach US …
The global Healthcare Contract Research Outsourcing Market was valued at US$ 61.6 Bn in 2025 and is projected to reach US$ 132.7 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 7.2% from 2026 to 2036. The market's steady expansion reflects the growing reliance of pharmaceutical, biotechnology, and medical device companies on Contract Research Organizations (CROs) to optimize development costs and accelerate time-to-market. In 2025, North America accounted
Cervical Cancer Diagnostic Tests Market Outlook 2036: Global Industry to Reach US$ 9.6 Billion by 2036 Driven by HPV Testing, Government Screening Programs, and Molecular Diagnostic Innovations
Cervical Cancer Diagnostic Tests Market Outlook 2036: Global Industry to Reach U …
The global cervical cancer diagnostic tests market is on a steady growth trajectory, reflecting the rising global focus on women's health, preventive oncology, and early disease detection. Valued at US$ 5.4 Bn in 2025, the market is projected to reach US$ 9.6 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. Cervical cancer remains one of the most common cancers affecting women worldwide,

All 5 Releases


More Releases for CRP

Finalized the ITT investment in CRP Technology and CRP USA
Modena, Italy, June 16th, 2022 - 3D printing leading companies CRP Technology and CRP USA have signed an investment agreement with ITT Inc., a diversified leading manufacturer of highly engineered critical components and customized technology solutions headquartered in Stamford, Connecticut (USA) and present in more than 35 countries. According to the operation, ITT Inc. becomes part of the shareholder structure of CRP Technology and CRP USA, in line with its business
CRP USA is AS9100 certified
CRP USA, pioneering company in the fields of Additive Manufacturing and high performance composite materials, announced it has recently achieved AS9100 Rev. D certification for the manufacture of 3D printed aerospace products from its customer's component design data. AS9100 Rev. D certification signifies CRP USA’s ongoing commitment to meeting and exceeding increasingly stringent industry requirements for aerospace related products. "We have taken our expertise in Additive Manufacturing solutions to new heights to
08-01-2019 | Sports
CRP Technology
CRP Technology shines at Sachsenring racetrack
Positive debut for the Italian-based companies and Energica’s technological partners for MotoE CRP Technology and CRP Meccanica made their debut at Sachsenring racetrack during the inaugural weekend of MotoE (5 – 7 July 2019) as Energica technological partners. The series had been stopped due to the Jerez fire but thanks to the hard work of Energica team and the partners involved, all Ego Corsa motorcycles were rebuilt in less than three months. The
CRP Technology is part of ARTES 4.0
CRP's cutting-edge AM technologies at the service of the most innovative projects in the field of Advanced Robotics CRP Technology participates as an affiliated member to ARTES 4.0 association (Advanced Robotics and enabling digital TEchnologies & Systems 4.0). The new born association leads the homonymous Competence Center coordinated by the Scuola Superiore Sant’Anna, and it is characterized as a partnership that connect universities, research institutes and companies focused on innovation. ARTES 4.0 Competence
MotoE™ ready to race thanks to CRP Meccanica and CRP Technology
Preparations are in progress for the resumption of the activities of the FIM Enel MotoE ™ World Cup after the setback last March, when a fire in Jerez destroyed much of the material for the MotoE™ , Ego Corsa machines included. CRP Technology and CRP Meccanica did not fail to give Energica (the FIM Enel MotoE ™ World Cup single manufacturer) their support on a par with the commitment made
CRP USA at AeroDef Manufacturing 2019
Stewart Davis, Director of Operations at CRP USA , will be attending AeroDef Manufacturing as speaker. The 2019 edition will be held from 29th April to 2nd May, 2019, at Long Beach Convention Center, Long Beach, California. At the 2019 edition Stewart Davis will be presenting the paper: “TuPOD, Cube Satellite and Tube Satellite dispenser produced via 3D Printing, successful launch orbit and dispensing of Two TubeSat”. The speech is set for